✦ LIBER ✦

A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials

✍ Scribed by J. Francart; E. Vaes; S. Henrard; C. Legrand; P. Baas; R. Gaafar; J.P. van Meerbeeck; R. Sylvester; A. Robert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of first-line bortezomib

✍ O’Brien, Mary E.R.; Gaafar, Rabab M.; Popat, Sanjay; Grossi, Francesco; Price, A 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 444 KB

An Exploratory Analysis of the Associati

✍ Lee, D.; Harvey, B.; Gaudin, A.F.; Gueron, B.; Bregman, B.; Lebbe, C.; Bonnetain 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

8021 The effect of anemia on the progres

✍ Sugiyama, T.; Kumagai, S.; Shouji, T.; Michimae, H.; Katsumata, N.; Tsuda, H.; A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB